Microplastics are now found almost everywhere, even in remote regions of Antarctica. They enter the human body through the food chain. Studies indicate that microplastics may have negative effects on ...
At the beginning of a busy week for the 3R community — just ahead of the THE 3R LÄND Conference 2026 — Tübingen became a meeting point for a different kind of exchange: f...
Mainz, Germany, March 10, 2026 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced plans for an independent company to be establish...
At a time of geopolitical tensions and growing supply shortages, surgical capability is becoming a critical factor for resilient health systems. Hellstern medical GmbH ha...
(Stuttgart/Tübingen) – Neurologists Prof. Justus Marquetand and Dr. Johannes Lang set up Cerebri GmbH in Tübingen, with the aim of making specialist electroencephalograms (EEGs) available to all patients. An EEG is an important test that is used...
(Stuttgart) – SustainMed is being extended. Work is now starting on SustainMed 2.0 – the follow-up funding project designed to work out preciseproposals for solutions to increase sustainability in the...
This year’s BioFIT in Strasbourg provided an ideal backdrop for two intensive and inspiring days for the STEP4NAMs consortium. On 1 December, our partners gathered for th...
Houston, Texas and Tuebingen, Germany, December 05, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company and the global leader in precision targ...
Dr. Sebastian Heiner is set to take over the position of CEO of Greiner Bio-One International GmbH on December 1, 2025. Dr. Heiner was most recently a member of the Execu...
Work in the SustainMed 2.0 project is continuing with full momentum. At the first joint working meeting, the focus was not only on getting to know the project partners in...
Technologieförderung Reutlingen-Tübingen GmbH is currently advertising laboratory and office space for research projects at the TF R-T BioMedTech Research Campus in Reutl...
(Stuttgart/Tübingen) – A new sensor-based diagnostics system is set to help improve treatment for conditions such as psychosis in young people. The SYMPATHJA project was ...
Houston, Texas and Tuebingen, Germany, November 12, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company and the g...
Tübingen, Germany – 05.11.2025 – LICIT Solutions completes Series A financing to accelerate the development and commercialization of next-generation sustainable active in...
Houston, Texas and Tuebingen, Germany, October 1, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company and the global leader in precision target...
A method developed at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB enables bacterial, viral, fungal, or parasitic pathogens in sepsis patien...
From October 7–8, 2025, the 7th edition of the HealthTech Innovation Days (HTID) took place in Paris – an event organized by HealthTech For Care, a European endowment fun...
How can new bio-based and biohybrid materials with improved features be developed faster? Six Fraunhofer institutes are jointly exploring this question in the SUBI²MA flagship project, using an innova...
The NMI and Reutlingen University are further strengthening their cooperation. On October 1, 2025, Dr. Xin Xiong, group leader of Biopolymers & Interfaces at the NMI,...
On September 9 and 10, 2025, the project partner meeting of the Interreg NWE project STEP4NAMs took place at the Golden Tulip Hotel Central in ’s-Hertogenbosch. Represent...
